Lots of people are hearing about Novavax, the fourth COVID vaccine option in the U.S., for the first time, but it's been authorized for use as a primary vaccine series since early 2022. Previously, it was only available for those who hadn't received a mRNA vaccine--an alternative for those who either couldn't or...
Lots of people are hearing about Novavax, the fourth COVID vaccine option in the U.S., for the first time, but it's been authorized for use as a primary vaccine series since early 2022. Previously, it was only available for those who hadn't received a mRNA vaccine--an alternative for those who either couldn't or...
Share this Article
Recommended